Dr. Kamel is Chief of the Division of Neurocritical Care and Director of the Clinical and Translational Neuroscience Unit in the Department of Neurology and the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine. His research focuses on identifying risk factors for ischemic stroke and developing treatments to prevent stroke.
